Inflammatory bowel diseases (IBD) encompass 2 chronic inflammatory conditions predominantly involving at the distal gastrointestinal tract, namely Crohn\'s disease (CD) and ulcerative colitis (UC). Both disorders are genetically complex and thought to arise from a combination of influences that trigger a symptom complex that at times may be indistinguishable from intestinal infection. Adherent--invasive strains of *Escherichia coli* and *Mycobacterium avium paratuberculosis* have been studied as putative triggers for IBD, but none of these agents has been causally linked with either disease, and clinical trials using targeted antibiotics have been disappointing.[@R1] One current pathophysiological model suggests that patients develop dysbiosis[@R2]; this could then lead to an abnormal mucosal immune response to commensal intestinal bacteria, resulting in chronic inflammation. Several metagenomic studies of gut microflora support this view and have hinted at a reduced microbial diversity in patients with IBD as well as an increased representation of specific lineages of microbes, such as the enterobacteriaceae. The alternative possibility persists that a single infectious agent, or related agents, may trigger the inflammatory response causing an imbalance of gut microbiota associated with a loss of tolerance to the microflora.

There are limited data available concerning the potential role that viruses may play in triggering IBD. Viral infection within the intestines may have a variety of consequences ranging from no obvious pathology to a global disturbance in gut physiology, modulation of the enteric immune system, and the disruption of the biophysical integrity of the bowel. Some viruses, such as cytomegalovirus (CMV), have a complex interaction with the disease process in IBD, where infection can manifest with the primary presentation of colitis or cause superimposed disease with the use of immunosuppressive therapy.[@R3],[@R4] Many viruses, including the herpesviridae, rubella, and measles viruses have been studied both serologically and in tissues, without any clear evidence of causal involvement in IBD.[@R5],[@R6] The potential for viral infection to trigger loss of tolerance to bacteria on a specific genetic background associated with CD has been demonstrated in an animal model and underscores the need to further document viral involvement in patients with IBD.[@R7],[@R8]

The study of viruses in IBD has been limited by the lack of systematic methodologies to detect potential agents. The advent of next-generation sequencing has made metagenomic analyses feasible for human studies, and this approach has been used to study viral communities in blood[@R9] and respiratory secretions[@R10] and for cataloging the collective DNA and RNA viral species in stool samples from healthy subjects[@R11],[@R12] and patients with IBD.[@R13] Metagenomic analysis has also served to discover viral agents in idiopathic neoplastic and inflammatory conditions where other approaches were unrevealing.[@R14],[@R15] Herein, we report for the first time the metagenomic analysis of viral sequences in colon RNA derived from patients with either CD or UC. Although these studies lack the ability to distinguish passenger viruses activated by inflammation and immunosuppression from potentially causal agents, our investigation provides a detailed description of the colonic virome in patients with IBD.

MATERIALS AND METHODS {#s1}
=====================

Patients {#s1-1}
--------

Colon samples were collected from patients undergoing surgery for IBD or from healthy subjects undergoing colonoscopy surveillance for polyps and cancer. The tissues were de-identified by diagnosis and stored at −80°C. Available patients and control samples were subsequently selected for this descriptive pilot study to determine the feasibility of using a metagenomic approach to describe the microbiome and virome in colon tissues. After metagenomic analyses, patients\' charts were reviewed for the use of medications before surgery (see Table, Supplemental Digital Content 1, <http://links.lww.com/IBD/A805>), the type of surgery performed and stratification of disease using the Montreal classification.[@R16] The University of Alberta Ethics Committee approved this investigation.

Sample Processing for Illumina Sequencing {#s1-2}
-----------------------------------------

Colonic tissue was homogenized, and total RNA was extracted with TRIzol (Invitrogen, CA). Genomic DNA was removed with DNase I (RNase-free, Qiagen, CA), and total RNA was further purified with RiboMinus (Invitrogen, CA) to remove human ribosomal RNA. Next-generation sequencing library construction was performed with Illumina mRNA-Seq Prep Kit following manufacturer\'s instructions (Illumina, CA). Approximately 2 GB of pair-end 75 bp to 90 bp sequence data consisting of about 30 million reads were generated per library using the Illumina HiSeq 2000 sequencing platforms.

Bioinformatic Pipeline for Viral Metagenomics {#s1-3}
---------------------------------------------

A bioinformatic pipeline was developed to optimize detection of low abundance viral sequences in human RNA and to avoid ambiguous annotation (Fig. [1](#F1){ref-type="fig"}).[@R9] Raw pair-end reads were first filtered with WindowMasker to remove low-quality low-complexity reads.[@R17] Ribosomal, mitochondrial, and centromere sequences were annotated using NCBI nt/nr with SOAPaligner[@R18],[@R19] and RepeatMasker aligned to RepBase 16.04. To maximize the detection of viral reads and subtract the background of human and bacteria, 3 databases were established from NCBI nt/nr database with the taxon ID including human, bacteria, and virus-specific databases for the multialignment stage.[@R9] The human database included the human genome assembly (GRCh37/hg19, February 2009) and all human transcript refseq from GenBank databases; virus and bacteria databases were constructed using taxon ID to extract all related sequences from nt/nr database.

![Bioinformatic pipeline for metagenomics. Reads were prefiltered and removed if they were low quality/complexity (∼7%), ribosomal RNA (∼69%), or mitochondrial RNA (∼6%). The remaining reads were assigned as human (∼17%) including HERV (∼0.006%), bacterial (∼1%), viral (∼0.001%), ambiguous (∼0.31%), or unclassified (∼3%) based on SOAPaligner or blastn.](ibd-21-1419-g001){#F1}

When we aligned reads against human, bacteria, and virus databases separately, we found some reads annotated as "equally best hits" with less than 3 bp variations within matched region from either 2 or all 3 databases. We assigned these reads to an ambiguous data set. Based on the annotation, we further categorized the data into 3 major processed data sets, namely human, bacteria, and virus that contained pair-end reads annotated with best hits only from the single database. The reads with no matches from all the 3 databases were assigned to an unclassified data set. To optimize the computing resources for this multialignment analysis, we first used SOAPaligner with default parameters.[@R18] This software is stringent and consumes less memory than blastn. This was used to acquire nearly perfect hits against human, bacteria, and virus database allowing a maximum variation of 5 bp with no gaps to the subject. After reducing the query size by SOAPaligner, we then used blastn to perform a second round of alignment with the unmatched reads using e-value \<1e^−5^ as the cutoff for all 3 databases. Pair-end relationship of reads and alignment results from both the SOAP and blastn searches were integrated to evaluate the accuracy of annotation for further categorization of different data sets.

We further extracted a subgroup to include the human endogenous retroviruses (HERVs) from the human data set. HERV reads were normalized as transcripts per million with total high-quality reads of each library for relative expression level. Statistical analysis (F-test) has been used to evaluate the significant difference of HERV abundance between samples with and without herpesviruses. The reads were classified into major family members of HERV-K, HERV-H, HERV-W, and a miscellaneous category. This classification is based on the amino acid of each specific transfer RNA used during replication; for example, the betaretrovirus family, HERV-K, uses lysine transfer RNA for priming reverse transcription.[@R20]

Verification of Virus Hits {#s1-4}
--------------------------

Viral reads were further analyzed by aligning against the whole viral genome using blastn with an e-value \<1e^−5^. To identify the most relevant viral genotypes and strains, the reads were also aligned against related viral genomes when available. Reads specific to 1 viral strain were considered unique reads, whereas reads aligning to multiple related entries were selected by the best alignment result with lowest e-value, longest matched length, and least variation to subject (Fig. [2](#F2){ref-type="fig"}). Based on the read distribution and coverage, viruses with multiple unique reads distributed along the whole genome were considered to be the most likely viral candidate within each clinical sample.

Bacterial Profiling {#s1-5}
-------------------

Reads from all libraries were pooled together for combined assembly. Bacterial data sets were further annotated from contigs/scaffolds using either a blastn or balstx e-value \<1e^−5^ to recover longer bacterial sequences for more accurate classification. Hierarchical clustering and principal component analysis (PCA) were used to further regroup among 15 samples based on the bacterial profiling using software MeV (4.8.1) and scripts written in R. A second data set was created for bacteriophage from the virus data set with taxon ID, and the phage data were stored with the bacterial data set.

RESULTS {#s2}
=======

Viral Sequences in Colon Samples {#s2-1}
--------------------------------

RNA libraries were made from colon samples derived from 10 patients with CD and UC (see Table, Supplemental Digital Content 1, <http://links.lww.com/IBD/A805>) and 5 subjects undergoing colonoscopy for colon cancer surveillance. Each colon library was sequenced on to a depth of approximately 30 million 75 bp to 90 bp pair-end reads that were subjected to analysis by the viral metagenomic pipeline (Fig. [1](#F1){ref-type="fig"}). The prefiltration process removed ribosomal sequences and low-quality reads, leaving approximately 7 million reads for further multialignment identification. On average, human sequences constituted 71% of reads in clinical tissue samples, bacteria accounted for 1% of reads, and viruses for less than 1% of reads. The number of verified viral reads varied among the 10 IBD libraries and ranged from 50 to 1000 (see Table, Supplemental Digital Content 2, <http://links.lww.com/IBD/A806>). Of the remaining reads, 3% were ambiguous and about 25% of reads were unclassified in need of further analysis.

A complexity of viruses was detected in the colon libraries (Fig. [3](#F3){ref-type="fig"}). Sequences aligning to these 15 different viruses were identified and verified by the detection of the same contiguous genomic sequence in the accompanying paired read. Among the 10 IBD samples, a relatively high diversity was observed ranging from 2 to 5 viral strains per library (Fig. [3](#F3){ref-type="fig"}). Human adenovirus was found in all IBD patient libraries (and none of the non-IBD patients), but the reads aligned to a conserved region of 1.2 kB, limiting our ability to distinguish specific adenovirus strains (Fig. [2](#F2){ref-type="fig"}). Herpesviridae sequences were observed in *cdC08*, *ucC06*, and *ucC07* (Fig. [2](#F2){ref-type="fig"}) but not in non-IBD patients. Initially, it was challenging to discriminate between the 2 strains of herpes simplex virus (HSV) in sample *ucC07*, as genetically both HSV-1 and HSV-2 genomes share 83% similarity. However, the HSV-1--like reads covered a shorter region of the genome and demonstrated a greater variance with HSV-1 (8.6%), and none were unique. Accordingly, the presence of HSV-2 could be inferred based on the higher genome coverage and unique read count (compare Fig. [2](#F2){ref-type="fig"}C and D). A complex infection with evidence of both Epstein--Barr virus (EBV) and CMV was observed in *cdC08* matching approximately 19 kB and 12 kB of each viral genome, respectively (Fig. [2](#F2){ref-type="fig"}A and B).

![Viral reads from individual libraries were aligned against reference viral genomes based on blastn to reference genomes, where red bars indicate number of reads that align only to 1 genome, whereas blue bars represent number of reads that align to multiple related genomes. Evidence for combined herpesviridae infection was observed in sample *cdC08* with (A) 286 reads matching approximately 19 kB of CMV genome and (B) 195 reads covering 12 kB of EBV genome (CMV, gi 155573622; EBV, gi 139424478). In sample *ucC07*, 434 reads matched HSV with a coverage of (C) 25,944 bp for the HSV-2 genome and (D) 14081 bp for the HSV-1 genome, suggesting the presence of HSV-2 (HSV-2, gi 9629267; HSV-1, gi 9629378). (E) Torque teno mini virus was also detected in sample *ucC07* (gi 295441877). (F), Human parvovirus B19 was detected in sample *cdC07* (gi 9632996).](ibd-21-1419-g002){#F2}

![Diversity of virome in IBD and cancer surveillance colon samples. Mammalian viruses and human pathogens were found with higher abundance in IBD colon libraries, whereas plant and other viruses were mainly observed in colon samples from patients undergoing colon cancer surveillance without documented disease (x-axis: patient samples, y-axis: viral families, z-axis: log plot of number of reads).](ibd-21-1419-g003){#F3}

In total, we observed a 1.0% variance from reference genomes for EBV, 1.6% for CMV, and 0.4% for HSV-2, suggesting the presence of these viruses in the colon samples. Other mammalian viral sequences were observed in the IBD libraries with nucleotide similarity to torque teno mini virus, parvovirus, and porcine endogenous retrovirus B. Furthermore, various plants and insects were detected in both IBD and control colon samples. In 1 CD library (*cdC07*), viral sequences resembling a nucleocytoplasmic large double-stranded DNA virus were detected that were related to paramecium bursaria chlorella virus. Although these megaviruses have not been previously reported in humans, the acanthocystis turfacea chlorella virus has recently been found in the oropharynx of humans with diminished performance on neurocognitive tests.[@R21]

HERV in IBD Colon Samples {#s2-2}
-------------------------

A small proportion of the human sequences detected in the IBD libraries were HERV, which constitute approximately 8% of the human genome. These elements are molecular fossils of ancient germ line retrovirus infection that have accumulated in the human genome throughout evolution. Although HERV expression does not indicate viral infection per se, the expression of HERV proteins has been linked with inflammatory and neoplastic conditions.[@R22]--[@R24] For example, reports have revealed that HERV expression can be activated by exogenous viral infection,[@R25] and expression of structural proteins can be cytotoxic in specific conditions.[@R22] In our initial evaluation, we observed that the HERV-K and HERV-H reads were far more abundant than HERV-W by more than 30-fold average transcripts per million. Two of the IBD libraries, *cdC08* and *ucC07*, had a very high relative abundance of HERV and also a higher diversity and abundance of viral strains as compared with the other samples (Fig. [2](#F2){ref-type="fig"}). Furthermore, the libraries containing herpesviruses had a 5- to 10-fold higher abundance of HERV as compared with those without (Fig. [4](#F4){ref-type="fig"}; see Table, Supplemental Digital Content 3, <http://links.lww.com/IBD/A807>). This is of potential interest because herpesviruses, such as EBV, have been reported to increase the transcriptional activity of HERV-K family members.[@R25]

![Abundance of HERVs (transcripts per million) in samples with herpesviruses (*cdC08*, *ucC06*, and *ucC07*) and without herpesviruses (*P* \< 0.01, F-test).](ibd-21-1419-g004){#F4}

Diversity of Bacteria and Phages {#s2-3}
--------------------------------

Bacterial sequences were observed in approximately 1% of reads, providing the opportunity to investigate the colonic microbiome within each library. To accomplish this, a combined assembly of all the bacterial reads from the 15 libraries was performed to recover longer contigs, which improved our ability to more closely identify related bacteria. We conducted a hierarchical clustering analysis using the abundance of bacteria in each library and then a PCA with scripts written in R language to determine the potential relationship of each library. Most of the IBD samples are clustered together (Fig. [5](#F5){ref-type="fig"}), and we observed a higher abundance of bacterial families that included the bradyrhizobiaceae, enterobacteriaceae, comamonadaceae, and moraxellaceae in the IBD samples, as previously reported for IBD.[@R1],[@R26]--[@R31] The PCA was consistent with the hierarchical clustering analysis and showed 2 predominant clusters with IBD and control subjects. Of interest, 3 samples with high viral diversity, including the 2 with predominant herpesvirus infection, appeared to disperse separately and did not fall into the 2 predominant clusters (Fig. [6](#F6){ref-type="fig"}).

![Hierarchical clustering of bacterial data sets based on transcripts per million (per sample counts ranging from 0 to about 2000). Clusters were identified from the bacterial profiling patterns on a per-bacterial-family (rows with distance values ranging from −0.12 to 1) and a per-sample (columns with distance values ranging from 0.08 to 1) basis. Most of the IBD samples clustered together except 2 UC colon samples marked with asterisks (*ucC03* and *ucC04* with limited viral sequences/diversity). Cluster of bacteria expressed at consistently higher levels in IBD samples as strongly associated with IBD in previous publications.](ibd-21-1419-g005){#F5}

![Three-dimensional PCA analysis on bacterial data sets subcategorized into 3 major groups: (1) the majority of the IBD samples (in green), (2) samples from patients undergoing colonic surveillance and 2 UC samples with limited viral sequences (in red: *ucC03* and *ucC04*), and (3) outliers of 3 IBD colon samples with relatively higher abundance of human viruses (in blue: *cdC05*, parvovirus B19; *cdC08*, CMV and EBV; *ucC07*, HSV-2 and torque teno virus).](ibd-21-1419-g006){#F6}

We observed that the majority of DNA viruses within the gut virome were bacteriophages. These viruses are reported to maintain a stable population within the gut microbiome over time with less than 20% differences in strains recorded over a 2-year period.[@R32] To study the bacteriaphage populations, we tabulated all bacteriophages and identified 119 different strains with unique reads that have been associated with 49 different bacterial host strains (see Table, Supplemental Digital Content 4, <http://links.lww.com/IBD/A808>). We studied the more diverse IBD colon samples and found the highly abundant phage groups in only 1 or 2 colon samples. For example, the *ucC07* library contained sequences homologous to several Enterococcus phages, Streptococcus phage phi-m46.1, Escherichia phage K1ind3, and others. In contrast, most of the other phages were observed in the multiple colon samples. This observation implies that a common phage--host population may be discovered in IBD colon samples along with the expected differences one would expect to be observed in individual patient samples.[@R13] Furthermore, we found that nearly half of the bacteriophages were associated with bacterial strains identified in the colon samples. Indeed, 5 strains were related to bacteria found in probiotics, like *Lactococcus lactis*, which may be linked with VSL\#3 probiotic therapy used to treat 2 of our patients (see Table, Supplemental Digital Content 1, <http://links.lww.com/IBD/A805>).

DISCUSSION {#s3}
==========

In this study, we developed a bioinformatic pipeline for defining the virome in colon samples processed by deep sequencing of total RNA depleted of ribosomes. This process was performed without any coculture or isolation procedure to provide data suggesting the presence of multiple virus strains. We observed a marked difference in both abundance of viruses and diversity within the virome of colons derived from IBD patients undergoing colonic surveillance for colon cancer. However, it is duly recognized that one of the weaknesses of this study was the comparison of surgical samples from patients with IBD and colonoscopic biopsies from our control subjects.

With this metagenomic approach of studying RNA from colon tissue, there was a paucity of viral reads (∼10 per million). In contrast, we observed that approximately 1 in 4 reads was unclassified, and these reads likely represent novel bacterial, viral, or other sequences that require further characterization, as noted by other studies.[@R9],[@R12],[@R33] However, the most striking finding was that the viral abundance and diversity were associated with differences in the bacterial composition within the colon. These data are consistent with the idea that viruses may contribute to the dysbiosis observed in patients with IBD, as recently demonstrated in an animal model of IBD,[@R7] by disturbing specific immune responses.[@R8] Moreover, samples with abundant herpesviridae also expressed elevated levels of HERV sequences that have been associated with pathology in other inflammatory disorders.[@R22],[@R25],[@R34],[@R35]

Within the known virus data set, we found strains that have been observed previously in the colon of patients with IBD. EBV has been found in previous case--control studies on IBD[@R36]--[@R38] and observed infecting intestinal lymphocytes in patients with UC and to a lesser extent those with CD.[@R39],[@R40] Intestinal CMV infection has been linked with exacerbation of IBD in extensive case--control studies.[@R39],[@R41]--[@R44] Human herpesvirus 2 has been associated with exacerbation of UC and may complicate disease in immunocompromised individuals.[@R45] Human papillomavirus has been linked with squamous cell carcinoma in patients with IBD.[@R46]--[@R48] Previous studies have reported serological evidence of parvovirus B19 in patients with IBD on immunosuppressive therapy[@R49] and B19 infection in the diseased intestinal mucosa of a patient with poorly controlled UC.[@R50] Accordingly, our metagenomic approach of using next-generation sequencing to discover viral sequences had the capacity to detect viruses in an unbiased fashion, as observed by other investigators using more conventional techniques.

We also identified additional viral strains in patients with IBD such as torque teno mini virus, which is commonly observed in humans without serious pathology.[@R51] As discussed, the detection of porcine endogenous retrovirus B sequences may have been related to the ingestion of pork. The detection of plant and insect viruses would also be expected from a dietary source, such as cassava vein mosaic virus, prunus necrotic ringspot virus, cauliflower mosaic virus, cucumber green mottle mosaic virus, and chilo iridescent virus.

Our pipeline also separated HERV and phage subsets from our virus data set to avoid ambiguous annotations of exogenous viral strains. We observed a marked diversity in both data sets from the IBD samples, suggesting a potential for these agents to impact on the complexity of the pathogenesis of IBD. For example, the diversity and abundance of HERV among IBD colon samples imply that infection of specific virus strains, such as herpesviridae, may trigger the expression of HERV in the colon,[@R34],[@R52],[@R53] consistent with previous reports in patients with autoimmune disorders and specific cancers.[@R35],[@R54],[@R55] However, it remains to be determined whether HERVs have any impact on the disease process in patients with IBD.

It is now appreciated that the high diversity of bacteria in the human gastrointestinal tract impacts on both health and disease, especially in patients with IBD.[@R30],[@R31],[@R56]--[@R61] Based on the hierarchical clustering and PCA analysis on bacterial data sets in colon biopsies, we identified a cluster of bacteria (Fig. [5](#F5){ref-type="fig"}) that have been consistently shown to have a higher abundance in IBD samples as compared with healthy subjects.[@R1],[@R26]--[@R31] The variety and abundance of phages found in colon samples are tightly associated with diversity of their bacterial hosts; accordingly, the bacteriophages detected within the colon samples likely highlight the bacterial host strains located in proximity to mucosal epithelial cells with relative strong adherent--invasive ability.[@R62]--[@R65] Indeed, we identified multiple phage strains associated with major pathogens associated with diarrhea or other intestinal symptoms.[@R39],[@R66],[@R67]

The presence of mammalian viral sequences also seemed to have a marked impact on the microbial diversity (Fig. [6](#F6){ref-type="fig"}). The interaction of viral infection with enteric microbiota has recently shown to be an important driver in models of IBD. For example, enteric bacteria enable norovirus infection of intestinal B lymphocytes,[@R8] suggesting a complex interaction of the microbiota and virus infection as highlighted by the *Atg16L1*-deficient mouse model. This mouse develops a CD-like disease after murine norovirus infection, which is preventable by administrating broad-spectrum antibiotics. The viral infection clearly alters the gut microflora because the disease can be passaged to healthy *Atg16L1*-deficient mice even after the viral infection apparently cleared.[@R7] The mechanism of viral--bacterial interaction in IBD requires further investigation, as discussed.[@R8] Accordingly, the findings reported in this study underscore the importance and clinical utility of a model where viral infection may alter the gut microbiome. Our data also emphasize the utility of using viral metagenomics to detect the potential of viral infection as a complicating factor in the pathogenesis and potential management of IBD. In future, additional studies will be required to more firmly link the metagenomic findings with clinical features of disease.
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